Analyst consensus rating
Annovis Bio Analyst Rating: none
Direct answer
Annovis Bio's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.50.
Forecast evidence checked November 12, 2026.
Get free Annovis Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.85
- Average price target
- $10.50
- High price target
- $17.00
- Low price target
- $7.00
- Low target gap
- +720.3%
- Target upside
- +1,130.5%
- High target gap
- +1,892.3%
- Target range width
- 1,171.9%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Annovis Bio?
Annovis Bio has a verified none consensus. The same dataset has an average price target of $10.50.
How far are Annovis Bio's low and high targets from the recorded price?
The low target implies +720.3%, while the high target implies +1,892.3%.
How many analysts are included in Annovis Bio's consensus?
The verified consensus includes 4 analysts.
How is Annovis Bio's target upside or downside calculated?
The average target of $10.50 is divided by the recorded price of $0.85, then one is subtracted to produce +1,130.5%. This does not guarantee a future return.
When was Annovis Bio's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.